EUCTR2004-000244-24-IT进行中（未招募）不适用
A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation.
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- PFIZER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation. - N/AMedDRA version: 7.0Level: LLTClassification code 10036596Premature EjaculationEUCTR2004-000244-24-CZPfizer Ltd.460
进行中（未招募）
1 期
A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation. - N/AMedDRA version: 7.0Level: LLTClassification code 10036596Premature EjaculationEUCTR2004-000244-24-ESPfizer, S.A.460
进行中（未招募）
不适用
A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation. - N/AMedDRA version: 7.0Level: LLTClassification code 10036596Premature EjaculationEUCTR2004-000244-24-HUPfizer Kft460
进行中（未招募）
不适用
A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation. - N/AMedDRA version: 7.0Level: LLTClassification code 10036596Premature EjaculationEUCTR2004-000244-24-SEPfizer AB460
已完成
不适用
A Phase 2b, Multi-center, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets on HbA1c in Subjects with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000017014Theracos, Sub., LLC320